Targeted Oncology
Latest Publications

TOTAL DOCUMENTS

852
(FIVE YEARS 75)

H-INDEX

39
(FIVE YEARS 0)

Published By Springer-Verlag

1776-260x, 1776-2596
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China

2022 ◽  
Author(s):  
Hai-Yan Tu ◽  
Jifeng Feng ◽  
Meiqi Shi ◽  
Jun Zhao ◽  
Yuyan Wang ◽  
...  
Keyword(s):  
Final Analysis ◽  
Open Label ◽  
Phase Iiib ◽  
Egfr Tki

scholarly journals Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study

2021 ◽  
Author(s):  
David Waterhouse ◽  
Laura Iadeluca ◽  
Sneha Sura ◽  
Keith Wilner ◽  
Birol Emir ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Observational Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
Community Oncology

MYL-1402O: A Bevacizumab Biosimilar

2021 ◽  
Author(s):  
Arnold Lee

Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma

2021 ◽  
Author(s):  
Veronica Mollica ◽  
Matteo Santoni ◽  
Marc R. Matrana ◽  
Umberto Basso ◽  
Ugo De Giorgi ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma

scholarly journals Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice

2021 ◽  
Author(s):  
Lishi Lin ◽  
Egbert F. Smit ◽  
Adrianus J. de Langen ◽  
Dorieke E. M. van Balen ◽  
Jos H. Beijnen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Practice ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Trial ◽  
Lung Cancer Patients ◽  
Egfr Mutated

scholarly journals Correction to: Durvalumab: A Review in Extensive-Stage SCLC

2021 ◽  
Author(s):  
Zaina T. Al-Salama
Keyword(s):  
Extensive Stage

A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies

2021 ◽  
Author(s):  
Toshio Shimizu ◽  
Yasutoshi Kuboki ◽  
Chia-Chi Lin ◽  
Kan Yonemori ◽  
Tomoko Yanai ◽  
...  
Keyword(s):  
Phase 1 ◽  
East Asian ◽  
Phase 1 Study ◽  
Asian Patients ◽  
East Asian Patients
Load More ...
Sign in / Sign up

Export Citation Format

Share Document